Global PCSK9 Inhibitors Market is expected to grow at a 15.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: There is a higher demand for novel treatments that can efficiently control chronic illnesses like high cholesterol. Healthcare practitioners are increasingly acknowledging the advantages of PCSK9 inhibitors in controlling elevated cholesterol levels, especially in patients who are ...
Report ID: 1298 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 185
Global Immunology Drugs Market Size is estimated to grow at a 10.5% CAGR during the forecast period for 2025-2034. The medical and biological research field known as Immunology Drugs focuses on the immune system. Autoimmune disorders develop when the immune system assaults the body that it is supposed to defend. People with autoimmune disorders have a deficiency in their immune system that prevents them from telling "self" molecules apart f...
Report ID: 1328 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 190
Live biotherapeutic/Microbiome Based Therapeutics Market Size is valued at USD 73.25 Bn in 2024 and is predicted to reach USD 142.81 Bn by the year 2034 at a 7.04% CAGR during the forecast period for 2025-2034. A live microbe is utilized in a Live Biotherapeutic product to treat, prevent, or cure a disease. Microorganisms that may be beneficial to health have been discovered as the human ...
Report ID: 1300 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Lipid-Nanoparticle Based Genomic Medicines Market Size is valued at USD 2.58 Bn in 2024 and is predicted to reach USD 38.04 Bn by the year 2034 at a 31.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The shift towards customized medicine is driving the lipid-nanoparticle-based genomic medicines market. The rise in mRNA-based therapeutics, enabled by lipid nanoparticles, is a signif...
Report ID: 2380 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Somatropin Market is expected to grow at a 7.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: One factor driving the growing demand for somatropin is the increasing frequency of growth hormone deficiency diagnoses in both adults and children, while another is the improvement in medical diagnostic technology, which permits earlier and more precise identification of growth hormone deficie...
Report ID: 1111 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global Neoantigen Cancer Vaccine Market is expected to grow at a 20.0% CAGR during the forecast period for 2025-2034. Neoantigen Cancer Vaccines are vaccines that assist in boosting the immune system by using a single or several antigens. The antigens generally consist of several peptides or proteins. Neoantigens are a mutated or a new type of antigen present only in cancer cells and not in rest normal cells. Neoantigen Cancer Vaccines stimulate...
Report ID: 1117 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
The Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Size is valued at 230.8 Million in 2024 and is predicted to reach 1,456.9 Million by the year 2034 at a 18.1% CAGR during the forecast period for 2025-2034 Key Industry Insights & Findings from the Report: Increasing R&D activities aimed at redefining the development of next-generation live biotherapeutic and microbiome contract manufac...
Report ID: 1152 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 190
Gene Therapy for Blood Disorders Market Size is estimated to grow at a 15.3% CAGR during the forecast period for 2025-2034. The Arena of Gene Therapy is determined to outline a path to the clinic and the market. In the gene therapy market, over 2000 human gene therapy clinical trials have been reported globally, and about 20 gene therapy products are approved to treat various disorders. Hence, the demand for gene therapy to treat blood disorde...
Report ID: 1156 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 185
Neuropsychiatric Drugs Market is expected to grow at a 5.0% CAGR during the forecast period for 2025-2034. Neuropsychiatric disorders are psychological disorder occur owing to a functional disturbance in the cerebral system. According to the National Institutes of Health, Neuropsychiatric disorders are one of the top 10 leading causes of global disability-adjusted life years (DALYs). The neuropsychiatry is concerned with illnesses of behavior ...
Report ID: 1170 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Head and Neck Cancer Market Size is estimated to grow at a CAGR of 8.5% during the forecast period for 2025-2034. According to the study published in NCBI (2014), head and neck cancer (HNC) is the sixth most common cancer worldwide, with an estimated 630,000 new cases every year. Specifically, this type of cancer includes tumors of the oropharynx, nasopharynx, hypopharynx, larynx, and oral cavity. Tobacco and alcohol consumption is strongly as...
Report ID: 1217 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Pharmaceuticals